Quick Takeaways
- GLAZER CAPITAL, LLC filed SCHEDULE 13G for Inozyme Pharma, Inc. Common stock, par value $0.0001 per share (INZY).
- Disclosed ownership: 6.6%.
- Date of event: 28 May 2025.
GLAZER CAPITAL, LLC - 28 May 2025 SCHEDULE 13G Report for Inozyme Pharma, Inc. Common stock, par value $0.0001 per share (INZY)
- Filing Manager
- GLAZER CAPITAL, LLC
- Reporting Manager
- Glazer Capital, LLC
- Symbol
- INZY
- Shares outstanding
- 64,521,093 shares
- Disclosed Ownership
- 4,251,940 shares
- Ownership
- 6.6%
- Form type
- SCHEDULE 13G
- Filing time
- 04 Jun 2025, 17:09:30 UTC
- Date of event
- 28 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GLAZER CAPITAL, LLC disclosed 6.6% ownership in Inozyme Pharma, Inc. Common stock, par value $0.0001 per share (INZY) on 28 May 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Jun 2025, 17:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 6.6% | 4,251,940 | 0 | 4,251,940 | Paul J. Glazer | Paul J. Glazer, Managing Member | |
| Paul J. Glazer | 6.6% | 4,251,940 | 0 | 4,251,940 | Paul J. Glazer | Paul J. Glazer |